| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.004 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.008 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.009 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |